Welcome to the 2022 annual report for Translational Lung Cancer Research. In 2022, the TLCR has continued its mission to increase the quality and impact of the journal, and to provide readers with a novel, well-organized, informative, enlightening and educational journal.
We would like to sincerely thank our Editorial Board Members, Guest editors, Reviewers, Authors, Readers for all your supports and contributions to TLCR in 2022, and we look forward to continuing our work with you in the new year.
Sincerely,
Editorial Office
Translational Lung Cancer Research
2022 Annual Report at PDF